Management of malignant hypercalcemia in cancer patients—a short review Clemens PetraschPetra MaricsThomas Spanberger short review 03 November 2023 Pages: 263 - 267
Genetic testing and management of prostate cancer patients with pathogenic germline variants Katharina ReiterMelanie R. Hassler short review Open access 03 November 2023 Pages: 51 - 56
Fifth-line HER2-directed therapy for metastatic adenocarcinoma of the gastroesophageal junction Sophie Roider-SchurSybille MachatLeopold Öhler case report 27 October 2023 Pages: 242 - 245
ASCO update—hepatocellular carcinoma and cholangiocellular carcinoma Angela Djanani short review Open access 27 October 2023 Pages: 234 - 236
Imaging and therapy targeting PSMA receptors for enhanced vision and precise treatment Sazan RasulStephan Korn short review Open access 19 October 2023 Pages: 251 - 254
Second-line treatment of HER2-positive advanced gastroesophageal adenocarcinoma Aysegül Ilhan-MutluEwald Wöll short review Open access 19 October 2023 Pages: 237 - 241
Prognostic factors of long-term survivors with unresectable pancreatic cancer: a retrospective analysis Giuseppe A. CollocaAntonella Venturino original report 17 October 2023
Cellular and humoral responses to fourth SARS-CoV-2 vaccination in a real-life cohort of patients with cancer Julia M. BergerPia GattingerMatthias Preusser special report Open access 13 October 2023 Pages: 63 - 66
Long-term survival and follow-up care after cancer in Austria Alexandra Böhm editorial 14 September 2023 Pages: 148 - 148
American Society of Hematology meeting update Dominik Wolf editorial 14 September 2023 Pages: 145 - 145
Brief update on systemic therapies in myeloproliferative neoplasms Janine SteichenDominik Wolf short review Open access 31 August 2023
Challenges in prevention, early detection, and management of febrile neutropenia in adult patients with solid tumors Petar Popov short review Open access 29 August 2023 Pages: 255 - 258
Erythropoiesis-stimulating agents—benefits and harms in the treatment of anemia in cancer patients Ronald HereggerRichard Greil short review Open access 28 August 2023 Pages: 259 - 262
New developments in radiation oncology for head and neck cancers Christoph ReslPetra GeorgCarmen Döller short review Open access 23 August 2023 Pages: 170 - 175
ASCO 2023: new treatment options in CNS tumors Josef Pichler short review 17 August 2023 Pages: 222 - 224
Late complications after oncological therapy Marco Hassler short review 15 August 2023 Pages: 180 - 184
FlASHback—personal highlights regarding myelodysplastic syndrome from the 2022 ASH meeting Verena PetzerDominik Wolf short review Open access 15 August 2023 Pages: 152 - 155
A GLOBAL CONGRESS DIGEST ON LUNG CANCER. Report from the ASCO Hybrid Congress , 2nd – 6th June 2023 Congress Report ASCO 2023: Lung Cancer 08 August 2023 Pages: 89 - 104
A GLOBAL CONGRESS DIGEST ON TARGETED THERAPIES IN B-CELL MALIGNANCIES. Report from the American Society of Clinical Oncology (ASCO) Annual Meeting (hybrid), 2nd-6th June 2023, European Hematology Association (EHA) 2023 Congress (hybrid), 8th-11th June 2023, and the 17th International Conference on Malignant Lymphoma (ICML) 2023 Congress (hybrid), 13th-17th June 2023 Congress Report ASCO, EHA, ICML 2023 08 August 2023 Pages: 105 - 124
Emerging molecular drugs for the treatment of gastroesophageal tumors Aysegül Ilhan-Mutlu leading article Open access 07 August 2023 Pages: 198 - 199
Aggressive B cell lymphomas—highlights from ASH 2022 Michael Panny short review 02 August 2023 Pages: 149 - 151
Current systemic treatment options and new developments in palliative first-line treatment of head and neck squamous cell carcinoma Florian KocherAndreas Seeber short review Open access 28 July 2023 Pages: 176 - 179
Next generation drugs in urothelial cancer: adenoviruses in the treatment of BCG-unresponsive nonmuscle invasive bladder cancer Dominik A. BarthMartin Pichler short review 25 July 2023 Pages: 189 - 192
Lipid nanoparticles in the treatment of lung cancer—hype or hope? Anna MairFabienne NoceraAndreas Pircher short review Open access 24 July 2023 Pages: 193 - 197
ASH highlights 2022—multiple myeloma Lina Z. RüsingHermine AgisMaria Krauth short review Open access 22 July 2023 Pages: 160 - 164
Hepatosplenic T-cell lymphoma with hemophagocytic lymphohistiocytosis, revealed by fever of unknown origin Kaoutar MelianiNoufissa Alami DribiRhyzlane Berrady case report 05 July 2023 Pages: 208 - 212
ASH 2022—new developments in acute myeloid leukemia Michael Pfeilstöcker review 20 June 2023 Pages: 156 - 159
Neoadjuvant and adjuvant therapy in early breast cancer. A short review on current clinical approaches Simon UdovicaKathrin Strasser-Weippl short review 08 May 2023 Pages: 125 - 128
ESMO update: upper gastrointestinal cancer Elisabeth S. BergenAysegül Ihan-Mutlu short review Open access 05 May 2023 Pages: 105 - 107
ESMO 2022 personal non-small lung cancer (NSCLC) highlights Lena HorvathGeorg Pall short review 05 May 2023 Pages: 97 - 99
Immunotherapy for metastatic melanoma—from little benefit to first-line treatment Christiane G. Mutz-RablPeter KoelblingerLukas Koch short review Open access 03 May 2023 Pages: 108 - 112
Lessons learned in adjuvant colorectal cancer Theresa SchmalfussHossein Taghizadeh short review Open access 28 April 2023 Pages: 113 - 115
How the long-term follow-up is organized in young adult survivors of childhood cancer Edit BardiLeo KagerWolfgang Holter short review Open access 27 April 2023 Pages: 185 - 188
Molecular pathology of colorectal cancer Petar NoackRupert Langer review Open access 27 April 2023 Pages: 116 - 121
A CONGRESS DIGEST ON RADIOLABELED THERANOSTICS FOR SOLID TUMORS. Report from the 35th Annual Congress of the European Association of Nuclear Medicine (EANM), October 15th – 19th, 2022, Barcelona Congress Report EANM 2022 26 April 2023 Pages: 75 - 88
A CONGRESS DIGEST ON NEUROENDOCRINE TUMORS. Report from the North American Neuroendocrine Tumor Society (NANETS) Annual Medical Symposium, 27th – 29th October 2022, Washington Congress Report NANETS 2022 26 April 2023 Pages: 65 - 74
Excellent response of a disseminated SMARCA4-deficient thoracic sarcomatoid tumor to immunochemotherapy—a case report Clemens PetraschSimon UdovicaAndrea Kaufmann-Keck case report 20 April 2023 Pages: 122 - 124
Selection of phase II/III breast cancer study highlights at the 2022 ESMO annual meeting Maximilian Marhold short review Open access 20 April 2023 Pages: 94 - 96
A GLOBAL CONGRESS DIGEST ON ON APPROACHES IN ADVANCED SOLID TUMORS. Report from the ESMO Immuno-Oncology Congress, 7th – 9th December 2022 Congress Report ESMO Immuno-Oncology 2022 20 April 2023 Pages: 53 - 64
A GLOBAL CONGRESS DIGEST ON TARGETED THERAPIES IN B-CELL MALIGNANCIES AND AML. Report from the American Society of Hematology (ASH) Annual Meeting, December 10–13, 2022 Congress Report ASH 2022 18 April 2023 Pages: 29 - 52
Assessment of nutritional status using objective and subjective methods in Greek patients with cancer Konstantina VamvakariIliana EvangelouOdysseas Androutsos original report Open access 22 March 2023 Pages: 200 - 207
ESMO 2022: spotlight on new emerging treatment options in central nervous system tumors Maximilian J. MairAnna S. Berghoff short review Open access 20 March 2023 Pages: 100 - 104
Position paper on CDK4/6 inhibitors in early breast cancer Michael GnantChristian F. SingerRupert Bartsch position paper Open access 14 March 2023 Pages: 135 - 144
Proceedings of the Annual Meeting of the Austrian Society of Haematology and Medical Oncology Abstracts OeGHO / AHOP 10 March 2023 Pages: 1 - 28
Spectrum of renal involvement in MGRS patients: a 6-year study Poornima TadkalVishwanath SiddiniMallikarjun Kalashetty original report 23 February 2023 Pages: 129 - 134
